Price
Free
Essential updates on the evolving SUD landscape
August 27
Webinar
This event is open to HANYS members and non-members.
Sharon Stancliff, MD, associate medical director for harm reduction in healthcare at the DOH AIDS Institute, will provide a crucial update on the evolving substance use crises. This session will explore current epidemiology, the complexities of substances like Kratom, K2 and xylazine, alongside innovative clinical responses and harm reduction strategies.
By the end of this session, participants will be able to:
Sharon Stancliff, MD, Associate Medical Director for Harm Reduction in Healthcare, Office of the Medical Director, AIDS Institute, New York State Department of Health
If you have questions regarding registration, please contact Registration Support at learning@hanys.org or 518.431.7867.
Sharon Stancliff, MD, associate medical director for harm reduction in healthcare at the DOH AIDS Institute, will provide a crucial update on the evolving substance use crises. This session will explore current epidemiology, the complexities of substances like Kratom, K2 and xylazine, alongside innovative clinical responses and harm reduction strategies.
By the end of this session, participants will be able to:
- analyze current epidemiology of the overdose crisis;
- describe the emerging trends in the overdose crisis, including novel substances; and
- identify and describe evidence-based treatment approaches and harm reduction strategies.
Sharon Stancliff, MD, Associate Medical Director for Harm Reduction in Healthcare, Office of the Medical Director, AIDS Institute, New York State Department of Health
If you have questions regarding registration, please contact Registration Support at learning@hanys.org or 518.431.7867.
